Loading clinical trials...
Loading clinical trials...
This is a prospective multicenter, group-matched study of patients with primary indeterminate lesions or choroidal melanoma who receive treatment with belzupacap sarotalocan (bel-sar; AU-011) and pati...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Aura Biosciences
NCT06007690 · Choroidal Melanoma, Indeterminate Lesions, and more
NCT03941379 · Choroidal Melanoma, Indeterminate Lesions of Eye
NCT01334008 · Choroidal Melanoma, Diffuse
NCT04417530 · Uveal Melanoma, Ocular Melanoma, and more
NCT03052127 · Uveal Melanoma, Ocular Melanoma, and more
Associated Retinal Consultants, P.C.
Royal Oak, Michigan
Oregon Health & Science University Casey Eye Institute
Portland, Oregon
Retina Consultants of Carolina, PA
Greenville, South Carolina
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions